Friday, June 14, 2019 2:20:12 PM
What Simps is pointing out is the complete lack of progression do to AW's constant blundering, and basically being handed deal after deal and refusing to take any of them. BIEL is a small biotech company, that has to sell shares to keep operating, that is something that is not sustainable! It will increase the dilution, which will further suppress the the stock price. Without a partner with deep pockets and brand awareness, it will be impossible for this stock to have any kind of sustained run or even get out of sub-penny, and that's with full FDA approval. And BIEL itself could go bankrupt as well.
So yes BIEL can sell a few Actipatches here a there, but without some kind of major deal or partnership, those sales really won't matter!
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM